# Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum

> **NCT06210217** · EARLY_PHASE1 · UNKNOWN · sponsor: **Sichuan University** · enrollment: 51 (estimated)

## Conditions studied

- Laparoscopic Hepatectomy

## Interventions

- **DRUG:** Dobutamine hydrochloride, Injectable
- **DRUG:** 0.9% normal saline

## Key facts

- **NCT ID:** NCT06210217
- **Lead sponsor:** Sichuan University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-01
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-04-07
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210217, "Effect of TEE-guided Non-fluid Limited Combined With Dobutamine on Hepatic Venous Blood Flow Spectrum". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06210217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*